4.6 Review

Considerations for the Analysis of Longitudinal Electronic Health Records Linked to Claims Data to Study the Effectiveness and Safety of Drugs

期刊

CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 100, 期 2, 页码 147-159

出版社

WILEY
DOI: 10.1002/cpt.359

关键词

-

资金

  1. Takeda training Fellowship
  2. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine at Brigham and Women's Hospital

向作者/读者索取更多资源

Health insurance claims and electronic health records (EHR) databases have been considered the preferred data sources with which to study drug safety and effectiveness in routine care. Linking claims data to EHR allows researchers to leverage the complementary advantages of each data source to enhance study validity. We propose a framework to evaluate the need for supplementing claims data with EHR and vice versa to optimize outcome ascertainment, exposure assessment, and confounding adjustment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据